Biodesix
BDSX
38 hedge funds and large institutions have $34.1M invested in Biodesix in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
11% more capital invested
Capital invested by funds: $30.7M → $34.1M (+$3.36M)
3% more funds holding
Funds holding: 37 → 38 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
0.16% less ownership
Funds ownership: 1.1% → 0.94% (-0.16%)
Top Buyers
Top Sellers
BDSX Hedge Fund Activity: Q4 2023 in Review
38 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q4 2023, worth a combined $34.1M — up 11% from $30.7M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BDSX positions and 3 closed out — a net gain of 2 holders — while 14 added to existing stakes and 10 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $124K. The largest seller was AIGH Capital Management, cutting an estimated $389K.
- 38 institutional investors held Biodesix (BDSX) as of Q4 2023, up from 37 in Q3 2023.
- Funds reported $34.1M of Biodesix stock for Q4 2023, up 11% quarter-over-quarter.
- 5 funds opened new Biodesix positions in Q4 2023 and 3 closed out, a net change of +2 holders.
- The largest Biodesix buyer in Q4 2023 was Geode Capital Management, an estimated $124K added.
- The largest Biodesix seller in Q4 2023 was AIGH Capital Management, an estimated $389K sold.
Based on aggregated 13F filings for Q4 2023.